Kuniko Hirota

Title: Kuniko Hirota: Innovator in Recombinant Baculovirus Vaccines

Introduction

Kuniko Hirota is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 2 patents, her work focuses on innovative solutions for infectious diseases.

Latest Patents

Hirota's latest patents include a recombinant baculovirus vaccine. This invention provides a novel transfer vector and a recombinant baculovirus, along with methods for their production. The pharmaceuticals containing the recombinant baculovirus serve as preventive or therapeutic drugs for infectious diseases such as malaria and influenza. More specifically, her invention includes a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter. The methods for preventing and treating infectious diseases involve administering the recombinant baculovirus to patients.

Career Highlights

Throughout her career, Kuniko Hirota has worked with notable organizations, including the Educational Foundation Jichi Medical University and Otsuka Pharmaceutical Company, Limited. Her experience in these institutions has allowed her to advance her research and contribute to the field of medical science.

Collaborations

Hirota has collaborated with esteemed colleagues such as Shigeto Yoshida and Masanori Kawasaki. These partnerships have further enriched her research and innovation efforts.

Conclusion

Kuniko Hirota's work in recombinant baculovirus vaccines showcases her dedication to addressing global health challenges. Her innovative approaches have the potential to make a significant impact on the prevention and treatment of infectious diseases.